Testimony of Dr. Diana Zuckerman About COPIKTRA FDA Advisory Committee Meeting on September 23, 2022 – Dr. Zuckerman of National Center for Health Research testified at FDA Advisory Committee in September 2022 about Copiktra for CLL and SLL. Compared to another treatment option that is no longer considered effective, Copiktra patients lived 11 months shorter with many serious problems harming quality of life.
Dietary Supplements Before and During Chemotherapy – People think of dietary supplements as a no-risk insurance policy to improve nutrition, but a study published in 2020 shows that supplements can have risks if you are undergoing chemotherapy.
What People With Cancer Need to Know about Coronavirus (COVID-19) – April 1, 2020. People will cancer need to be especially careful when it comes to the coronavirus. Here’s what you need to know. Questions? Don’t hesitate to contact us.
How to Report Problems With Medical Products to the FDA – If you or someone you know has had an adverse event after taking an approved drug, you should report to the FDA. Here’s how.
Radiation Therapy for Ductal Carcinoma In Situ (DCIS) – Radiation and hormone therapy both have benefits for most women who undergo lumpectomy, because they decrease the chances of DCIS returning after surgery.